Clinical Trial Update: Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients

View source ↗

Summary

A completed clinical trial examining direct measurements of cardiometabolic risk in patients with schizophrenia who are being treated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Schizophrenia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Schizophrenia, Cardiovascular Disease | Status: COMPLETED